Kaiser Permanente Ventures
Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Business Model:
Revenue: $15M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kaiser Permanente Ventures Information
Geographic Data
Address: 1 Kaiser Plaza
City: Oakland
State: CA
Zip: 94612
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$141M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2020 | Kate Farms | Series B | 51M |
| 7/2016 | Torax Medical | Series E | 0 |
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 2/2019 | Health Catalyst | Series F | 0 |
| 4/2014 | Omada Health | Series B | 23M |
| 11/2001 | NextWeb | Series C | - |
| 3/2012 | AtheroMed | Series D | 4.5M |
| 10/2008 | Predictive Biosciences | Series B | 21.8M |
| 9/2009 | ValenTx | Series B | 0 |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 8/2020 | Freenome | Series C | 270M |
| 8/2022 | Everytable | Series C | 0 |
| 8/2009 | Silverlink Communications | Series D | 5M |
| 9/2011 | Valeritas | Series C | 150M |
| 7/2021 | Osso VR | Series B | 0 |
| 4/2007 | Bacchus Vascular | Venture Round | 6.5M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 4/2022 | IntelyCare | Series C | 0 |
| 4/2014 | Transcend Medical | Series C | 0 |
| 7/2019 | Nuvolo | Series B | 12M |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 1/2022 | Big Health | Series C | 0 |
| 9/2022 | Kate Farms | Series C | 75M |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 9/2013 | Xanitos | Venture Round | 0 |
| 2/2009 | Arcxis Biotechnologies | Series B | - |
| 6/2016 | Bluesight | Series C | 20.4M |
| 12/2015 | Vidyo | Series E | 15M |
| 6/2010 | Baxano | Series C | 30M |
| 1/2015 | Bluesight | Series B | 12M |
| 4/2015 | Validic | Series B | 12.5M |
| 6/2020 | Big Health | Series B | 39M |
| 11/2020 | Everytable | Series B | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 1/2007 | Calypso Medical | Series D | 42.2M |
| 3/2020 | Ordr | Series B | 6M |
| 2/2020 | IntelyCare | Series B | 45M |
| 3/2021 | Evidation Health | Series E | 153M |
| 10/2022 | NorthOne | Series B | 0 |
| 2/2019 | Health Catalyst | Debt Financing | 0 |
| 1/2014 | Health Catalyst | Series C | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 4/2013 | Vapotherm | Series A | 0 |
| 2/2008 | Accumetrics | Series D | 0 |
| 11/2015 | Vapotherm | Series C | 0 |
| 7/2019 | Freenome | Series B | 160M |
| 1/2005 | GeneOhm Sciences | Series C | 0 |
| 6/2012 | TriVascular | Series D | 60M |
| 6/2012 | Astute Medical | Series C | 40.4M |
| 7/2014 | Valeritas | Series D | 45M |
| 9/2019 | Ginger | Series C | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 2/2008 | Zonare Medical Systems | Equity | 30M |
| 3/2021 | Nuvolo | Series C | 32M |
| 3/2015 | Health Catalyst | Series D | 0 |
| 1/2023 | NOCD | Series B | 0 |
| 7/2017 | Protenus | Series A | 3M |
| 3/2021 | DexCare | Series A | 0 |
| 6/2023 | DexCare | Series C | 0 |
| 7/2015 | Vapotherm | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 11/2013 | TriVascular | Series E | 0 |
| 11/2017 | Collective Medical Technologies | Series A | 47.5M |
| 11/2007 | Vapotherm | Series E | 11.3M |
| 8/2008 | Vapotherm | Series F | 20.5M |
| 9/2020 | Osso VR | Series A | 14M |
| 9/2014 | MetricStream | Private Equity Round | 60M |
| 1/2005 | CHF Solutions | Venture Round | 22.9M |
| 9/2012 | Torax Medical | Series D | 0 |
| 3/2013 | Health Catalyst | Series B | 0 |
| 11/2002 | NextWeb | Series D | 1.5M |
| 5/2010 | Oxford Immunotec | Series D | 26M |
| 7/2020 | Genome Medical | Series B | 0 |
| 11/2018 | Vesta Healthcare | Series A | 10M |
| 6/2021 | Protenus | Series D | 0 |
| 3/2012 | GluMetrics | Venture Round | 13.3M |
| 9/2021 | NOCD | Series B | 0 |
| 1/2013 | Nordic | Funding Round | 38.3M |
| 4/2005 | BDNA | Series C | 12.5M |
| 1/2018 | Protenus | Series B | 11M |
| 6/2010 | Predictive Biosciences | Series C | 25M |
| 6/2016 | Kit Check | Series C | 0 |
| 8/2019 | Protenus | Series C | 0 |
| 1/2012 | CytoPherx | Series C | 34M |
| 8/2020 | Ginger | Series D | 0 |
| 5/2021 | Groups Recover Together | Series C | 60M |
| 1/2015 | Kit Check | Series B | 12M |
| 8/2005 | NextWeb | Series E | 3.5M |
| 4/2013 | iRhythm Technologies | Series D | 16M |
| 1/2012 | iRhythm Technologies | Private Equity Round | 12.2M |
| 4/2014 | Vapotherm | Series B | 0 |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 1/2020 | Vesta Healthcare | Series A | 30M |
| 9/2010 | Accumetrics | Venture Round | 0 |
| 8/2005 | Adiana | Series D | 23M |
| 6/2013 | Movable | Seed | 1.9M |
| 10/2009 | Accumetrics | Series E | 0 |
| 7/2016 | Big Health | Series B | 0 |
| 1/2012 | Transcend Medical | Series B | 16M |
| 4/2013 | Nordic | Venture Round | 5M |
| 12/2004 | Radianse | Venture Round | 2M |
| 12/2014 | Ginger | Series B | 20M |
| 4/2013 | AtheroMed | Private Equity Round | 6M |
| 11/2022 | Validic | Venture Round | 12M |
| 2/2016 | CareGuardian | Series B | 5M |
| 6/2012 | Oxford Immunotec | Equity | 28M |
| 1/2015 | Ingenious Med | Venture Round | - |
| 6/2011 | Transcend Medical | Series B | 51M |
| 1/2018 | Genome Medical | Series A | 11M |
| 11/2011 | Xanitos | Venture Round | 0 |
| 8/2022 | Everytable | Series C | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 4/2022 | IntelyCare | Series C | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 9/2021 | NOCD | Series B | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 7/2021 | Osso VR | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
